CONDORELLI, Gianluigi
 Distribuzione geografica
Continente #
NA - Nord America 8.240
EU - Europa 1.506
AS - Asia 947
AF - Africa 242
SA - Sud America 11
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.957
Nazione #
US - Stati Uniti d'America 8.200
SG - Singapore 498
FI - Finlandia 415
IE - Irlanda 339
CN - Cina 326
NG - Nigeria 240
DE - Germania 155
FR - Francia 121
IT - Italia 117
SE - Svezia 92
NL - Olanda 83
IN - India 63
GB - Regno Unito 51
RU - Federazione Russa 39
CA - Canada 36
BE - Belgio 35
CZ - Repubblica Ceca 22
IL - Israele 18
JP - Giappone 13
TR - Turchia 11
GR - Grecia 8
UA - Ucraina 6
AR - Argentina 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
HK - Hong Kong 4
NO - Norvegia 4
RO - Romania 4
CL - Cile 3
CU - Cuba 3
PE - Perù 3
TH - Thailandia 3
TW - Taiwan 3
DK - Danimarca 2
EG - Egitto 2
IR - Iran 2
KR - Corea 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
IM - Isola di Man 1
LI - Liechtenstein 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
Totale 10.957
Città #
Chandler 1.715
Wilmington 1.487
San Mateo 550
Ann Arbor 473
Helsinki 415
Boardman 373
Dublin 338
New York 312
Singapore 311
Shanghai 286
Leawood 248
Lawrence 241
Princeton 241
Benin City 240
Ashburn 141
Woodbridge 133
Fairfield 126
Paris 118
Amsterdam 79
Pune 58
Seattle 52
San Diego 50
London 47
Los Angeles 41
Brussels 35
Milan 35
Norwalk 29
Toronto 28
Moscow 26
Falls Church 24
Abbiategrasso 21
Falkenstein 19
Brno 17
Phoenix 15
Houston 11
Kocaeli 11
Santa Clara 11
Des Moines 9
Monmouth Junction 8
Redmond 8
Munich 7
Rome 7
Tappahannock 6
Hanover 5
Olomouc 5
Ottawa 5
St Louis 5
Wuhan 5
Dronten 4
Hangzhou 4
Pradleves 4
Tokyo 4
Augsburg 3
Bangkok 3
Beijing 3
Clearwater 3
Havana 3
Lima 3
Novokuznetsk 3
Oslo 3
Redwood City 3
Washington 3
Andover 2
Auckland 2
Cairo 2
Changsha 2
Chicago 2
Chisinau 2
Copenhagen 2
Covilha 2
Eden Prairie 2
Ferrara 2
Grottaglie 2
Henderson 2
La Plata 2
Lenexa 2
Lübeck 2
Milwaukee 2
Naples 2
Procida 2
Quilmes 2
Richmond 2
Saint Paul 2
Sale Marasino 2
St Petersburg 2
Taipei 2
Troia 2
Turin 2
Yuncheng 2
Alexandria 1
Bandon 1
Belgrade 1
Berlin 1
Birmingham 1
Bologna 1
Bolton 1
Brest 1
Brisbane 1
Buenos Aires 1
Canton 1
Totale 8.538
Nome #
T cell costimulation blockade blunts pressure overload-induced heart failure 66
The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300 64
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 64
Electroactive polyurethane/siloxane derived from castor oil as a versatile cardiac patch, part II: HL-1 cytocompatibility and electrical characterizations 63
Interleukin-6 Trans-Signaling and Risk of Future Cardiovascular Events: A New Avenue for Atheroprotection? 63
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling 62
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 62
Adenovirus-mediated gene transfer of the retinoblastoma family member p130/RB2 blocks restenosis after endothelial injury 61
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 61
MicroRNAs and cardiac pathology 60
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 60
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis 59
Uses and compositions comprising mirnas 59
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 59
Aerobic interval training enhances cardiomyocyte contractility and Ca2+ cycling by phosphorylation of CaMKII and Thr-17 phospholamban 57
Endovascular treatment vs. intravenous thrombolysis alone for ischaemic stroke: a meta-analysis of randomised controlled trials 57
Therapeutic use of microRNAs in myocardial diseases 56
Genetic variants in CCNB1 associated with differential gene transcription and risk of coronary in-stent restenosis 56
Dr. John Ross Jr. 56
Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials 56
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 56
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy. 56
DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy 55
The emerging role of microRNAs in cardiovascular biology 55
Inhibition of Class I Histone Deacetylase with an Apicidine Derivative Prevents Cardiac Hypertrophy and Failure 55
Inhalation Therapy Delivers Nanoparticle-Based Therapeutic Biomolecules To The Diseased Heart 55
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy 55
Mutated p21/WAF/CIP transgene overstatement reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice 54
Activation of cAMP-PKA signalling in vivo inhibits smooth muscle cell proliferation after vascular injury 54
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials 54
Molecular determinants of the physiological adaptation to stress in the cardiomyocyte: a focus on AKT 53
Chemerin processing in the myocardium: A mechanism in search of a function 53
Translating cardioprotection for patient benefit : position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology 53
ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes 53
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population 53
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 53
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes 52
[Continuity of care in heart failure: pilot study of the Tuscany region]. 52
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy 52
A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block. 51
p300/CBP modulates co-operation between MEF2A and TR/RxR 51
The possible role of chromosome X variability in hypertensive familiarity. 51
Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use? 50
Differential expression and functional role of GATA-2, NF-E2 and GATA-1 in normal adult erythropoiesis 50
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure 50
Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy 50
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 50
Effects of Akt on cardiac myocytes: location counts 49
The earliest iodination site of thyroglobulin is residue number 5. The Journal of Biological Chemistry 49
Akt1 gene transfer to the endothelium corrects impaired endothelial dependent vasorelaxation in hypertensive rats 49
Physiological myocardial hypertrophy: how and why? 49
ATP6V0A1 polymorphism and microRNA-637: A pathogenetic role for microRNAs in essential hypertension at last? 49
Defining circulating mononuclear cells in heart failure through single-cell RNA sequencing: new insights for an old disease 49
Human stem cells for heart failure treatment ready for prime time? 48
Prolonged duration of myocardial ischemia in patients with coronary artery disease and impaires cardiopulmonary baroreceptor sensitivity 48
Antiphosphotyrosine recovery of an isulin-stimulated receptor phosphatase activity in FRTL5 cells 48
Arterial remodeling and atherosclerosis: miRNAs involvement 48
Association of FOXO3A locus with extreme longevity in the Southern Italian Centenarian Study 48
A Nitric Oxide-releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure 48
MicroRNAs as Companion Biomarkers for the Diagnosis and Prognosis of Acute Coronary Syndromes 48
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice 48
A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts 48
Abnormal responses to saline load in hypertensive patients with parental history of cardiovascular accidents 48
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years 48
Circulating microRNAs and aerobic fitness : the HUNT-study 47
Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis. 47
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts 47
Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17 47
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway 47
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 47
Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression 46
mTOR regulates brain morphogenesis by mediating GSK3 signaling. 46
An autofluorescence-based method for the isolation of highly purified ventricular cardiomyocytes 46
MicroRNAs in cardiovascular disease: an introduction for clinicians 46
Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure 45
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease 45
RBP and microRNA control of endothelial cell function 45
Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary SMC and in early lesions of WHHL rabbits: protective effects of vitamin E 45
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia 45
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease 45
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia 45
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents 45
Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients 45
MicroRNA and cardiac pathologies 44
Epigenetics : a new mechanism of regulation of heart failure? 44
Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases : per aspirin ad astra 44
Circular RNAs and heart failure: new players for an old disease 44
The circulating level of FABP3 is an indirect biomarker of microRNA-1 44
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 44
Single-Cell Sequencing of Mouse Heart Immune Infiltrate in Pressure Overload-Driven Heart Failure Reveals Extent of Immune Activation 44
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo 44
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice 44
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 44
MicroRNAs and cardiac conduction 44
Stem cells for cardiomyocyte regeneration: state of the art 43
The cdc2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle 43
Developmental regulation of Rb in normal adult erythropoiesis: peak expression and functional role in advanced erythroid differentiation. 92: 43
miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases 43
Enforced Tal-1 expression stimulates primitive, erythroid and megacaryocytic progenitor but blocks the granulopoietic differentiation program 43
Regulation of cell size and contractile function by AKT in cardiomyocytes 43
Totale 5.062
Categoria #
all - tutte 84.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/20212.644 21 28 19 9 25 832 348 195 541 355 11 260
2021/20221.206 31 20 20 315 20 18 42 201 102 91 245 101
2022/20234.485 544 116 346 553 500 398 4 419 839 394 300 72
2023/20242.551 213 245 550 147 78 368 144 151 43 69 176 367
2024/2025240 145 93 2 0 0 0 0 0 0 0 0 0
Totale 11.131